Trappe, Ralf <br/><br/>
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.  [electronic resource] 

 -  The Lancet. Oncology  Feb 2012 
 - 196-206 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(11)70300-X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antigens, CD20--immunology<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Epstein-Barr Virus Infections--diagnosis<br/>Female<br/>France<br/>Germany<br/>Herpesvirus 4, Human--pathogenicity<br/>Humans<br/>Lymphoproliferative Disorders--drug therapy<br/>Male<br/>Middle Aged<br/>Organ Transplantation--adverse effects<br/>Prednisolone--administration & dosage<br/>Prospective Studies<br/>Rituximab<br/>Vincristine--administration & dosage